Skip to main
SIBN

SI-BONE Inc (SIBN) Stock Forecast & Price Target

SI-BONE Inc (SIBN) Analyst Ratings

Based on 6 analyst ratings
Strong Buy
Strong Buy 83%
Buy 17%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

SI-BONE is a promising investment due to its strong financial performance, strategic partnerships, and innovative products. They are poised for continued growth in the future, with plans to expand into new markets and product launches. However, there are potential risks such as reimbursement issues and competition, which should be closely monitored. With a specialized sales force and unique assets, the company remains a top pick for investors looking for high growth potential in the medical device industry.

Bears say

SI-BONE is facing potential headwinds in the near term, including potential downward pressure on average selling prices and the impact of proposed DRG changes. Additionally, the company's conservative revenue guidance may overlook potential catalysts, such as the potential contribution from the SNN partnership in 2H26 and the planned launch of a third novel implant system in 4Q26. While the company has a strong growth profile and a clear pathway to profitability, multiple compression within the industry may limit upside potential for the stock.

SI-BONE Inc (SIBN) has been analyzed by 6 analysts, with a consensus rating of Strong Buy. 83% of analysts recommend a Strong Buy, 17% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of SI-BONE Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About SI-BONE Inc (SIBN) Forecast

Analysts have given SI-BONE Inc (SIBN) a Strong Buy based on their latest research and market trends.

According to 6 analysts, SI-BONE Inc (SIBN) has a Strong Buy consensus rating as of Aug 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $24.17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $24.17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

SI-BONE Inc (SIBN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.